Target intelligence / Profile preview

Human urate transporter 1 (URAT1)

Target
URAT1
Molecular classification
Transporter, Solute carrier family (SLC22), Organic anion transporter (OAT subfamily)
01

Overview

Human urate transporter 1 (URAT1, SLC22A12) is an integral membrane protein localized in the apical membrane of renal proximal tubule epithelial cells. It operates as an antiporter, exchanging intracellular organic anions or chloride ions for extracellular urate, thus crucially controlling urate reabsorption into the bloodstream. The transporter’s activity depends on a network of highly conserved amino acid residues that form a hydrophobic binding pocket, ensuring selective urate transport, and undergoes conformational changes between inward, outward, and occluded states during the transport cycle. This mechanism can be pharmacologically inhibited, and several drugs target URAT1 directly to lower serum urate, making it a prime target for treating gout and hyperuricemia. Genetic variations in URAT1 can influence urate affinity and transport efficiency, potentially affecting drug response and disease risk.

Other names
SLC22A12solute carrier family 22 member 12urate channelurate transporter 1 (URAT1)
02

Mechanism of action

Pharmacological inhibition of urate reabsorption (reducing serum urate by blocking URAT1; drug binding interferes with urate or counteranion binding in the transport cycle)

03

Biological functions

Urate (uric acid) reabsorption in renal proximal tubulesRegulation of serum urate levelsAntiport (exchange of urate with organic anions or chloride)Maintenance of metabolic homeostasis
04

Disease associations

GoutHyperuricemiaChronic kidney disease (by modulating urate levels)Potentially involved in cardiovascular disease risk
05

Safety considerations

Risk of renal impairment or toxicity if urate excretion is excessive or if counter-anion exchange is dysfunctionalDrug interactions with other organic anion transporters in the kidney, potentially affecting excretion of other drugs or metabolitesPotential off-target effects in individuals with polymorphisms in URAT1 or related proteins
06

Interacting drugs

Lesinurad

4 more in the full profile.

07

Biomarkers

Serum urate concentration (for patient selection and efficacy monitoring of URAT1 inhibitors)

Beyond the preview

Go deeper on Human urate transporter 1 (URAT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human urate transporter 1 (URAT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call